Market By Product, Application, End-user And Geography | Forecast 2019-2027
The report by Triton on the Asia-Pacific western blotting market states that the market is headed towards expansion with a rise of 6.80% in CAGR during the forecast period of 2019 to 2027.
The countries that have been studied in the report on Asia-Pacific’s western blotting market are:
• China
• Japan
• India
• South Korea
• ASEAN Countries
• Australia & New Zealand
• Rest of Asia-Pacific
The Asia-Pacific is the fastest-growing regional market in terms of revenue generation. According to AVERT, an estimated 5.1 million people in APAC were living with HIV in the year 2015. In addition, there is a high prevalence rate of Hepatitis B in the Asia-Pacific region. A very small proportion of the Asia-Pacific adult population has been tested and counselled for HIV. Owing to the lack of well-defined criteria & treatment guidelines, HIV and Hepatitis B are underdiagnosed in Asia. This ever-increasing number of HIV affected people is a major factor boosting market growth in this region.
Report scope can be customized per your requirements. Request For Customization
The presence of supportive government initiatives and nonprofit organizations, such as the WHO and the UNAIDS, that focus on increasing the HIV testing rate through Voluntary Counselling and Testing (VCT) and reducing the prevalence rate of HIV, are some of the crucial factors that are anticipated to propel the growth of the Asia-Pacific regional market for western blotting over the forecast period. In addition, continuous R&D activities and strategic alliances by key market players for designing enhanced and innovative products are expected to fuel the market growth over the forecast period.
Moreover, the booming biotechnology sector and increased funding for agriculture & proteomic research in countries such as India and China are expected to fuel the market growth over the forecast period. India, Japan, and China are the major contributors to the growth of the western blotting market in the APAC region. Furthermore, with growing partnerships & collaborations between universities and pharma companies, the pharmaceutical R&D sector is emerging in the Chinese market. Thus, such collaborations and the flourishing Japanese pharmaceutical industry are increasingly encouraging the demand for western blotting required for research activities.
Thermo Fisher Scientific, Inc., is a manufacturer and developer of analytical instruments & equipment, reagents & consumables, and diagnostics. Its portfolio of products includes technologies for genetic sequencing, electron microscopy, mass spectrometry, protein, and molecular biology research. Thermo Fisher Scientific serves its products to academic & research institutions, pharmaceutical & biotech companies, government agencies & clinical diagnostic labs; and industrial quality & process control and environmental sectors. The company operates in Germany, China, the UK, Singapore, India, and Switzerland. Thermo Fisher Scientific is headquartered in Waltham, Massachusetts.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1.
ASIA-PACIFIC WESTERN BLOTTING MARKET - SUMMARY
2.
INDUSTRY OUTLOOK
2.1. MARKET DEFINITION
2.2. KEY INSIGHTS
2.2.1. ASIA-PACIFIC DOMINATES THE OVERALL WESTERN
BLOTTING MARKET
2.2.2. GROWING NUMBER OF APPLICATIONS FOR WESTERN
BLOTTING
2.2.3. GROWING ACCEPTANCE OF DIGITAL WESTERN
BLOTTING
2.3. PORTER’S FIVE FORCE ANALYSIS
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE
2.3.3. BARGAINING POWER OF SUPPLIERS
2.3.4. BARGAINING POWER OF BUYERS
2.3.5. THREAT OF COMPETITIVE RIVALRY
2.4. MARKET ATTRACTIVENESS INDEX
2.5. VENDOR SCORECARD
2.6. MARKET DRIVERS
2.6.1. GROWING OCCURRENCE OF HIV AND LYME DISEASE
2.6.2. HIGH DEMAND FOR PROTEOMICS
2.6.3. RISE IN APPLICATIONS FOR WESTERN BLOTTING
2.7. MARKET RESTRAINTS
2.7.1. ADVANCEMENTS IN SUBSTITUTE TECHNOLOGIES
2.8. MARKET OPPORTUNITIES
2.8.1. INDUSTRIALIZATION OF WESTERN BLOT INSTRUMENTS
2.9. MARKET CHALLENGES
2.9.1. INFLATED COST OF ANTIBODIES
2.9.2. GROWING RESEARCH INITIATIVES AND R&D
EXPENDITURE BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
3.
WESTERN BLOTTING MARKET OUTLOOK - BY PRODUCT
3.1. CONSUMABLES
3.1.1. REAGENTS AND BUFFERS
3.1.2. KITS
3.1.3. OTHER CONSUMABLES
3.2. INSTRUMENTS
3.2.1. GEL ELECTROPHORESIS INSTRUMENTS
3.2.2. BLOTTING SYSTEMS
3.2.2.1. DRY BLOTTING SYSTEMS
3.2.2.2. SEMI-DRY BLOTTING SYSTEMS
3.2.2.3. WET BLOTTING SYSTEMS
3.2.3. IMAGERS
3.2.3.1. CHEMILUMINESCENT IMAGERS
3.2.3.2. FLUORESCENT IMAGERS
3.2.3.3. OTHER IMAGERS
4.
WESTERN BLOTTING MARKET OUTLOOK - BY APPLICATION
4.1. BIOMEDICAL & BIOCHEMICAL RESEARCH
4.2. DISEASE DIAGNOSTICS
4.3. AGRICULTURE
4.4. OTHER APPLICATIONS
5.
WESTERN BLOTTING MARKET OUTLOOK - BY END-USER
5.1. RESEARCH INSTITUTES
5.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
5.3. DIAGNOSTIC CENTERS
5.4. OTHER END-USERS
6.
WESTERN BLOTTING MARKET - REGIONAL OUTLOOK
6.1. ASIA-PACIFIC
6.1.1. CHINA
6.1.2. JAPAN
6.1.3. INDIA
6.1.4. SOUTH KOREA
6.1.5. ASEAN COUNTRIES
6.1.6. AUSTRALIA & NEW ZEALAND
6.1.7. REST OF ASIA-PACIFIC
7.
COMPETITIVE LANDSCAPE
7.1. F. HOFFMAN LA-ROCHE LTD.
7.2. MERCK KGAA
7.3. THERMO FISHER SCIENTIFIC INC.
7.4. BIO-RAD TECHNOLOGIES INC.
7.5. BIO-TECHNE CORPORATION
7.6. CELL SIGNALING TECHNOLOGY INC.
7.7. GE HEALTHCARE
7.8. LI-COR INC.
7.9. ADVANSTA
7.10. AZURE BIOSYSTEMS INC.
7.11. PERKINELEMER INC.
7.12. ROCHE DIAGNOSTICS INTERNATIONAL INC.
7.13. ROCHE DIAGNOSTICS
7.14. LUMIGEN INC.
7.15. ROCKLAND IMMUNOCHEMICALS INC.
8.
METHODOLOGY & SCOPE
8.1. RESEARCH SCOPE
8.2. SOURCES OF DATA
8.3. RESEARCH METHODOLOGY
TABLE 1. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN
$ MILLION)
TABLE 2. MARKET ATTRACTIVENESS INDEX
TABLE 3. VENDOR SCORECARD
TABLE 4. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY COUNTRY, 2019-2027 (IN
$ MILLION)
TABLE 5. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY PRODUCT, 2019-2027 (IN
$ MILLION)
TABLE 6. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY APPLICATION, 2019-2027
(IN $ MILLION)
TABLE 7. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY END-USER, 2019-2027
(IN $ MILLION)
FIGURE 1. PORTER’S FIVE FORCE ANALYSIS
FIGURE 2. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY CONSUMABLES,
2019-2027 (IN $ MILLION)
FIGURE 3. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY REAGENTS AND BUFFERS,
2019-2027 (IN $ MILLION)
FIGURE 4. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY KITS, 2019-2027 (IN $
MILLION)
FIGURE 5. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY OTHER CONSUMABLES,
2019-2027 (IN $ MILLION)
FIGURE 6. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY INSTRUMENTS,
2019-2027 (IN $ MILLION)
FIGURE 7. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY GEL ELECTROPHORESIS
INSTRUMENTS, 2019-2027 (IN $ MILLION)
FIGURE 8. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY BLOTTING SYSTEMS,
2019-2027 (IN $ MILLION)
FIGURE 9. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY DRY BLOTTING SYSTEMS,
2019-2027 (IN $ MILLION)
FIGURE 10. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY SEMI-DRY BLOTTING
SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 11. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY WET BLOTTING
SYSTEMS, 2019-2027 (IN $ MILLION)
FIGURE 12. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY IMAGERS, 2019-2027
(IN $ MILLION)
FIGURE 13. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY CHEMILUMINESCENT
IMAGERS, 2019-2027 (IN $ MILLION)
FIGURE 14. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY FLUORESCENT IMAGERS,
2019-2027 (IN $ MILLION)
FIGURE 15. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY OTHER IMAGERS,
2019-2027 (IN $ MILLION)
FIGURE 16. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY BIOMEDICAL &
BIOCHEMICAL RESEARCH, 2019-2027 (IN $ MILLION)
FIGURE 17. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY DISEASE DIAGNOSTICS,
2019-2027 (IN $ MILLION)
FIGURE 18. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY AGRICULTURE,
2019-2027 (IN $ MILLION)
FIGURE 19. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY OTHER APPLICATIONS,
2019-2027 (IN $ MILLION)
FIGURE 20. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY RESEARCH INSTITUTES,
2019-2027 (IN $ MILLION)
FIGURE 21. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY PHARMACEUTICAL &
BIOTECHNOLOGY COMPANIES, 2019-2027 (IN $ MILLION)
FIGURE 22. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY DIAGNOSTIC CENTERS,
2019-2027 (IN $ MILLION)
FIGURE 23. ASIA-PACIFIC WESTERN BLOTTING MARKET, BY OTHER END-USERS,
2019-2027 (IN $ MILLION)
FIGURE 24. ASIA-PACIFIC WESTERN BLOTTING MARKET, REGIONAL OUTLOOK, 2018
& 2027 (IN %)
FIGURE 25. CHINA WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 26. JAPAN WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 27. INDIA WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 28. SOUTH KOREA WESTERN BLOTTING MARKET, 2019-2027 (IN $ MILLION)
FIGURE 29. ASEAN COUNTRIES WESTERN BLOTTING MARKET, 2019-2027 (IN $
MILLION)
FIGURE 30. AUSTRALIA & NEW ZEALAND WESTERN BLOTTING MARKET,
2019-2027 (IN $ MILLION)
FIGURE 31. REST OF ASIA-PACIFIC WESTERN BLOTTING MARKET, 2019-2027 (IN $
MILLION)